™
At SITES Medical, we focus on developing and de-risking innovative orthopedic technologies that enhance your product offerings. We collaborate with you to seamlessly integrate them into your product lines and bring them to market.
Our featured platform technology is OsteoSync Ti, a porous ingrowth material trusted by our OEM partners and marketed under various brand names. Additionally, we offer a range of technologies to meet your needs, including:
For orthopedic OEMs, SITES Medical provides comprehensive concept-to-launch R&D services, including regulatory filings. We provide a one-stop shopping approach, handling the entire process or specific parts, and can collaborate with your clinical team or help you build one using our extensive network. While our R&D services typically focus on projects involving our technologies, we’re open to considering other projects.
Our agile manufacturing platform allows us to produce smaller batch sizes economically, matching end-customer demand and reducing inventory requirements. The system is underpinned by a near-zero machine setup time which allows us to switch from one production part number to another with virtually no measurable downtime. This capability is enabled by SITES Medical’s proprietary Dimensional Stabilization technology as well as standard fixturing, automated production and inspection.
At SITES Medical, we excel in several markets to meet your specific needs:
Orthopedic
(Hips, Knees, Extremities, Trauma, Sports)
Spine
(Interbody Fusion Devices, Disc Replacements, VBRs, Pedicle Screws, Plates)
Dental
(Implants, Reconstructive Meshes)
Other
(Vet, CMF, Cochlear)
Our deep expertise in these areas ensures that we provide you with the most advanced and effective solutions.
Nanovis, Inc. announced the acquisition of certain of its nano surface technology assets and certain of its rights to intellectual property assets related to Sites Medical’s OsteoSyncTMTitanium and related polymer molding technologies (used in fixed height PEEK/OsteoSync interbodies) by Medtronic for use in the development of Medtronic’s next generation PEEK interbody fusion devices.
Market acceptance of OsteoSync Ti continues to grow as we mark another key milestone for the technology – over 250,000 devices implanted! Our OEM partners appreciate OsteoSync Ti for its best-in-class bone ingrowth, high initial stability, ability to attach to various substrates (including Co-Cr and Ti), and compatibility with different coating technologies.
Microport is excited to announce the newest addition to the Evolution® Revision Knee family – Evolution® Tibial Cones. Designed to tackle the challenges of bone loss and poor bone quality encountered in complex revision knee surgeries, these versatile cones are made from OsteoSync® Ti and offer surgeons a reliable, efficient solution to improve patient outcomes.
SITES Medical in growth mode. In response to significantly increased demand for our OsteoSync Ti porous ingrowth technology, we’ve added six new, state-of-the-art wire EDM machines which are used in the manufacturing process.
Another milestone for OsteoSync Ti: Over 200,000 devices implanted. Our OEM partners have their own tradenames for it, but they all appreciate OsteoSync Ti for its best-in-class bone ingrowth, high initial stability and the ability to attach to various substrates, including Co-Cr and Ti.
SITES Medical celebrates its 15th anniversary. From humble beginnings and a focus on a singular technology, we have expanded our offering of platform technologies and added contract R&D and manufacturing services to provide a rapid product concept-to-launch process to support our OEM customers.
Spineology Inc., an innovator in anatomy-conserving surgery, is excited to launch the Duo Ti Expandable Interbody Fusion Procedure, which combines Spineology’s proprietary mesh technology with OsteoSync porous titanium to deliver a large, anatomy conforming implant via anatomy-conserving lateral decubitus and prone approaches.